Park Avenue Securities’s Bath & Body Works BBWI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,961
Closed -$209K 1638
2025
Q2
$209K Buy
+6,961
New +$204K ﹤0.01% 1421
2025
Q1
Sell
-6,972
Closed -$270K 1196
2024
Q4
$270K Buy
+6,972
New +$233K ﹤0.01% 1323
2024
Q3
Sell
-6,916
Closed -$270K 1384
2024
Q2
$270K Buy
6,916
+216
+3% +$9.91K ﹤0.01% 1223
2024
Q1
$335K Buy
6,700
+666
+11% +$29.9K ﹤0.01% 1137
2023
Q4
$260K Buy
+6,034
New +$204K ﹤0.01% 1180
2023
Q2
Sell
-15,459
Closed -$565K 725
2023
Q1
$565K Buy
15,459
+1,467
+10% +$61.5K 0.01% 582
2022
Q4
$590K Buy
13,992
+1,269
+10% +$47.3K 0.01% 718
2022
Q3
$415K Buy
12,723
+926
+8% +$32.7K 0.01% 785
2022
Q2
$318K Buy
11,797
+3,271
+38% +$142K 0.01% 893
2022
Q1
$408K Buy
8,526
+5,607
+192% +$303K 0.01% 832
2021
Q4
$204K Buy
+2,919
New +$207K ﹤0.01% 1056
2021
Q3
Sell
-7,261
Closed -$423K 1030
2021
Q2
$423K Sell
7,261
-525
-7% -$28.4K 0.01% 699
2021
Q1
$389K Sell
7,786
-2,074
-21% -$85.4K 0.01% 671
2020
Q4
$296K Buy
+9,860
New +$286K 0.01% 692

Other funds holding BBWI

Park Avenue Securities's BBWI Position: Q3 2025 in Review

Park Avenue Securities sold out of Bath & Body Works (BBWI) in Q3 2025, closing a stake of 6,961 shares — an estimated $209K sold.

Park Avenue Securities first reported a position in BBWI in Q4 2020 and held it in 14 quarters. The position peaked at $590K in Q4 2022. 473 funds tracked by Wall St. Rank hold BBWI as of Q3 2025.

  • Park Avenue Securities reported no remaining Bath & Body Works position as of Q3 2025 after selling out during the quarter.
  • Park Avenue Securities sold 6,961 Bath & Body Works shares in Q3 2025, an estimated $209K.
  • Park Avenue Securities first reported a position in Bath & Body Works in Q4 2020 and held it in 14 quarters.
  • Park Avenue Securities's Bath & Body Works position peaked at $590K in Q4 2022.
  • 473 funds tracked by Wall St. Rank held Bath & Body Works as of Q3 2025.

Based on Park Avenue Securities's 13F filing for Q3 2025, filed 23 Oct 2025.